Reducing Adverse Drug Reactions for Older People in the Community: Evaluating the Validity and Reliability of the ADRe Profile

IF 3.7 2区 医学 Q2 MANAGEMENT
Vera Logan, Neil Carter, David Hughes, Adam Turner, Sue Jordan
{"title":"Reducing Adverse Drug Reactions for Older People in the Community: Evaluating the Validity and Reliability of the ADRe Profile","authors":"Vera Logan,&nbsp;Neil Carter,&nbsp;David Hughes,&nbsp;Adam Turner,&nbsp;Sue Jordan","doi":"10.1155/jonm/9921349","DOIUrl":null,"url":null,"abstract":"<div>\n <p><b>Background:</b> Adverse drug reactions (ADRs), particularly in the context of polypharmacy, remain a persistent, unresolved problem for patients and healthcare professionals. The ADRe Profile identifies medicine-related harms, and supports their resolution, thereby improving care quality and preventing future problems.</p>\n <p><b>Objective:</b> The objective of this study was to assess the validity and reliability of the ADRe Profile (https://www.swansea.ac.uk/adre/) in U.K. primary care general practices, building on assessments in other settings.</p>\n <p><b>Methods:</b> The ADRe Profile’s validity and reliability were investigated using complementary mixed methods: content validity index, contrast group construct validity, cognitive interviewing, and inter-rater reliability.</p>\n <p><b>Results:</b> Cognitive interviews (<i>n</i> = 5) confirmed that the ADRe Profile needed only minor adjustments. The scale-level content validity index was 0.67 (<i>n</i> = 14), items ranging from 0.08 to 1. Significant differences in signs and symptoms associated with ADRs between service users taking different numbers of regular prescribed medicines confirmed construct validity (<i>n</i> = 68, <i>U</i> = 870.50, <i>p</i> &lt; 0.001). Inter-rater reliability testing showed substantial agreement between service users and research nurse: 10 items had 100% agreement. Overall <i>kappa</i> mean was 0.71 (range: 0.31–1), (<i>n</i> = 42).</p>\n <p><b>Conclusions and Relevance:</b> The ADRe Profile is suitable for use with older service users in primary care who live at home. Users understood the questions and provided meaningful answers. ADRe Profile responses were sufficiently reliable to be used as a basis for further investigations, prescriber referral and clinical actions. However, clinician judgement of content validity may depend on knowledge and experience, highlighting the importance of training. Clinicians acknowledged that the ADRe Profile was comprehensive but identified practical difficulties. Instruments to reduce ADRs should be validated before testing in feasibility studies and randomised controlled trials.</p>\n <p><b>Implications for Nursing Management:</b> Managers need to optimise patient safety by introducing patient-centred symptom monitoring, with decision support. Before instruments are adopted, managers should check the reliability and validity data.</p>\n <p><b>Trial Registration:</b> ClinicalTrials.gov identifier: NCT04663360</p>\n </div>","PeriodicalId":49297,"journal":{"name":"Journal of Nursing Management","volume":"2025 1","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/jonm/9921349","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nursing Management","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/jonm/9921349","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MANAGEMENT","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Adverse drug reactions (ADRs), particularly in the context of polypharmacy, remain a persistent, unresolved problem for patients and healthcare professionals. The ADRe Profile identifies medicine-related harms, and supports their resolution, thereby improving care quality and preventing future problems.

Objective: The objective of this study was to assess the validity and reliability of the ADRe Profile (https://www.swansea.ac.uk/adre/) in U.K. primary care general practices, building on assessments in other settings.

Methods: The ADRe Profile’s validity and reliability were investigated using complementary mixed methods: content validity index, contrast group construct validity, cognitive interviewing, and inter-rater reliability.

Results: Cognitive interviews (n = 5) confirmed that the ADRe Profile needed only minor adjustments. The scale-level content validity index was 0.67 (n = 14), items ranging from 0.08 to 1. Significant differences in signs and symptoms associated with ADRs between service users taking different numbers of regular prescribed medicines confirmed construct validity (n = 68, U = 870.50, p < 0.001). Inter-rater reliability testing showed substantial agreement between service users and research nurse: 10 items had 100% agreement. Overall kappa mean was 0.71 (range: 0.31–1), (n = 42).

Conclusions and Relevance: The ADRe Profile is suitable for use with older service users in primary care who live at home. Users understood the questions and provided meaningful answers. ADRe Profile responses were sufficiently reliable to be used as a basis for further investigations, prescriber referral and clinical actions. However, clinician judgement of content validity may depend on knowledge and experience, highlighting the importance of training. Clinicians acknowledged that the ADRe Profile was comprehensive but identified practical difficulties. Instruments to reduce ADRs should be validated before testing in feasibility studies and randomised controlled trials.

Implications for Nursing Management: Managers need to optimise patient safety by introducing patient-centred symptom monitoring, with decision support. Before instruments are adopted, managers should check the reliability and validity data.

Trial Registration: ClinicalTrials.gov identifier: NCT04663360

减少社区老年人药物不良反应:评估ADRe档案的效度和可靠性
背景:药物不良反应(adr),特别是在多药的背景下,仍然是一个持续的,未解决的问题,为患者和医疗保健专业人员。ADRe概况识别与药物相关的危害,并支持其解决,从而提高护理质量并预防未来的问题。目的:本研究的目的是评估英国初级保健全科实践中ADRe概况(https://www.swansea.ac.uk/adre/)的有效性和可靠性,并建立在其他情况下的评估基础上。方法:采用内容效度指数、对照组构念效度、认知访谈、量表间信度等互补混合方法对ADRe量表的效度和信度进行研究。结果:认知访谈(n = 5)证实,ADRe概况只需要轻微的调整。量表水平内容效度指数为0.67 (n = 14),题项范围为0.08 ~ 1。服用不同数量常规处方药的服务使用者与不良反应相关的体征和症状存在显著差异,证实了结构效度(n = 68, U = 870.50, p <;0.001)。量表间信度测试显示服务使用者与研究护士之间有相当大的一致性:10项100%一致。总体kappa平均值为0.71(范围:0.31-1),(n = 42)。结论和意义:ADRe档案适用于居家的老年初级保健服务使用者。用户理解问题并提供有意义的答案。ADRe Profile反应足够可靠,可作为进一步调查、处方推荐和临床行动的基础。然而,临床医生对内容效度的判断可能依赖于知识和经验,突出了培训的重要性。临床医生承认ADRe概况是全面的,但也发现了实际困难。在进行可行性研究和随机对照试验之前,应对减少不良反应的仪器进行验证。对护理管理的影响:管理人员需要通过引入以患者为中心的症状监测来优化患者安全,并提供决策支持。在使用仪器之前,管理者应该对数据的信度和效度进行检查。试验注册:ClinicalTrials.gov标识符:NCT04663360
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
9.40
自引率
14.50%
发文量
377
审稿时长
4-8 weeks
期刊介绍: The Journal of Nursing Management is an international forum which informs and advances the discipline of nursing management and leadership. The Journal encourages scholarly debate and critical analysis resulting in a rich source of evidence which underpins and illuminates the practice of management, innovation and leadership in nursing and health care. It publishes current issues and developments in practice in the form of research papers, in-depth commentaries and analyses. The complex and rapidly changing nature of global health care is constantly generating new challenges and questions. The Journal of Nursing Management welcomes papers from researchers, academics, practitioners, managers, and policy makers from a range of countries and backgrounds which examine these issues and contribute to the body of knowledge in international nursing management and leadership worldwide. The Journal of Nursing Management aims to: -Inform practitioners and researchers in nursing management and leadership -Explore and debate current issues in nursing management and leadership -Assess the evidence for current practice -Develop best practice in nursing management and leadership -Examine the impact of policy developments -Address issues in governance, quality and safety
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信